aoporphan.at
Provided by Alexa ranking, aoporphan.at has ranked N/A in N/A and 8765457th on the world. It is hoted in N/A with IP address 188.94.250.30. The home page has 0 external link.
Top keyword related from Search Engine of aoporphan.at
Traffic Ranks of aoporphan.at
Owner: |
N/A |
RANK: |
8765457 |
Country code: |
N/A |
Country name: |
N/A |
Rank on country: |
N/A |
Host: |
N/A |
Ip: |
188.94.250.30 |
Ref link: |
|
Extension: |
at |
-
1. AOP Health: AOP Health - Needs.Science.Trust
Link: https://www.aop-health.com/global_en
Description: WebAOP Orphan Pharmaceuticals GmbH Member of the AOP Health Group. Leopold-Ungar-Platz 2 1190 Vienna, Austria +43 1 503 72 44-0 office[at]aoporphan. com. Reporting of …
-
3. AOP Health: Rebranding: AOP Orphan is now AOP Health
Link: https://www.aop-health.com/global_en/press/press-releases/rebranding-aop-orphan-is-now-aop-health/
Description: WebAll of AOP Orphan’s business units and subsidiaries have now been united under the new AOP Health brand. Vienna, 20.01.2022. Previously known as AOP Orphan, AOP Health …
-
4. AOP Health: About AOP Health
Link: https://www.aop-health.com/global_en/about-us/about-aop-health/
Description: WebAOP Orphan Pharmaceuticals GmbH Member of the AOP Health Group. Leopold-Ungar-Platz 2 1190 Vienna, Austria +43 1 503 72 44-0 office[at]aoporphan. com. Reporting of …
-
5. BESREMi® (Ropeginterferon alfa-2b) approved by the US FDA
Link: https://www.businesswire.com/news/home/20211115005741/en/BESREMi%C2%AE-Ropeginterferon-alfa-2b-approved-by-the-US-FDA
Description: WebNov 15, 2021 · AOP Orphan Pharmaceuticals GmbH (AOP Orphan) is an international pharmaceutical company with its headquarters in Vienna and a focus on rare and special …
-
6. AOP Orphan: a European pioneer in the field of rare and
Link: https://www.healtheuropa.com/aop-orphan-a-european-pioneer-in-the-field-of-rare-and-complex-diseases/106462/
Description: AOP OrphanExpansion and GrowthPatient Services: Care and Compliance For A Better Quality of LifeIntegrated Patient ServicesThe Many Meanings of ‘Care’ in HealthcareUser Responses and Feedback OrphaCare GmbH, part of the Austria-based AOP Orphan Group, develops and implements innovative and customised therapy solutions for patients with rare diseases which require complex treatments. The company focuses on medical devices, paired with organising accompanying care services tailored to the patient’s needs, in order to find the best possibl...
OrphaCare GmbH, part of the Austria-based AOP Orphan Group, develops and implements innovative and customised therapy solutions for patients with rare diseases which require complex treatments. The company focuses on medical devices, paired with organising accompanying care services tailored to the patient’s needs, in order to find the best possibl...
-
7. AOP Health | LinkedIn
Link: https://www.linkedin.com/company/aop-health
Description: WebPreviously known as AOP Orphan, AOP Health is the European pioneer for integrated therapies for rare diseases and in critical care. Over the past 25 years, the company has …
-
8. Interview: Rudolf Widmann – CEO and Founder, AOP Orphan, …
Link: https://pharmaboardroom.com/interviews/interview-rudolf-widmann-ceo-and-founder-of-aop-orphan-austria/
Description: WebOct 24, 2017 · Rudolf Widmann, CEO and founder of AOP Orphan, the first rare disease-specific European company, discusses the overriding goal to ensure rare disease …
-
9. Andreas Steiner, CEO of AOP Orphan Pharmaceuticals
Link: https://www.theceomagazine.com/executive-interviews/healthcare-pharmaceutical/andreas-steiner/
Description: WebApr 29, 2021 · One way that AOP Orphan is working to ensure long-term viability is by investing heavily in research and development. “We typically invest about 20% of our revenues in research, and that’s a really big …
-
10. Blood Cancer: AOP Health Announces New Findings in Patients …
Link: https://www.businesswire.com/news/home/20231207901630/en/Blood-Cancer-AOP-Health-Announces-New-Findings-in-Patients-With-Polycythemia-Vera-to-Be-Presented-at-the-American-Society-of-Hematology-ASH-65th-Annual-Meeting
Description: WebDec 7, 2023 · SAN DIEGO-- ( BUSINESS WIRE )-- AOP Orphan Pharmaceuticals GmbH (AOP Health), Vienna, Austria, announced the results of an analysis assessing the …